RecruitingNot ApplicableNCT07278973

Hemodiafiltration Versus Hemodialysis in Older People

HemoDiafiltration Versus HemoDialysis in OLDER People: a Randomized, Multicenter, Crossover, Pragmatic Clinical Trial


Sponsor

AUB Santé

Enrollment

62 participants

Start Date

Feb 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF). Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis. These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.


Eligibility

Min Age: 85 Years

Inclusion Criteria7

  • Signed and dated informed consent
  • Age \>84 years
  • Diagnosed with kidney failure
  • On maintenance hemodialysis \>3months
  • Willing to have a dialysis session of 3.5 to 4-hour duration, three times a week
  • Has a reliable vascular access
  • Is covered by the health insurance

Exclusion Criteria5

  • Patients with cognitive impairment (assessed with a mini-test if needed)
  • Hospitalized at inclusion
  • Have difficulties with French speaking
  • Terminally ill with life expectancy\<3 months
  • With active cancer

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHigh-flux hemodialysis

High-flux hemodialysis removes small and middle molecular solutes through the mechanism of diffusion.

OTHERHemodiafiltration

Hemodiafiltration removes solutes using convection which allows for more epuration of middle molecular solutes.


Locations(4)

AUB Santé

Bretagne, France

AIDER

Grabels, France

ECHO

Le Mans, France

Aura Paris

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07278973


Related Trials